OPALEYE MANAGEMENT INC. purchased 2.5% of their position (71.06K shares) of GRACE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $136.2K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 10/17/2026ACC: 0001493152-26-047473
10% Owner
Since Aug 2026
+71.06K
Net shares
Net buyer
$136.2K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
71.06K acquired
Non-Derivative Transactions3
Common Stock, par value $0.0001 per share
Indirect
Shares
+11.23K
Price / share
$1.93
Trade value
$21.73K
% of position
0.4%
10/14/2026
2.87M→2.88M
Common Stock, par value $0.0001 per share
Indirect
Shares
+23.48K
Price / share
$1.95
Trade value
$45.69K
% of position
0.8%
10/15/2026
2.88M→2.91M
Common Stock, par value $0.0001 per share
Indirect
Shares
+36.35K
Price / share
$1.89
Trade value
$68.76K
% of position
1.2%
10/16/2026
2.91M→2.94M
Total
Net shares
+71.06K
Net value
$136.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Indirect | 10/14/2026 | P · Purchase | +11.23K | $1.93 | $21.73K | 0.4% | 2.87M | 2.88M |
| Common Stock, par value $0.0001 per share Indirect | 10/15/2026 | P · Purchase | +23.48K | $1.95 | $45.69K | 0.8% | 2.88M | 2.91M |
| Common Stock, par value $0.0001 per share Indirect | 10/16/2026 | P · Purchase | +36.35K | $1.89 | $68.76K | 1.2% | 2.91M | 2.94M |
| Total | +71.06K | $136.18K | ||||||
Derivative Transactions0
No derivative transactions reported